Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,082 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis.
Kawai T, Taguchi S, Nakagawa T, Kamei J, Nakamura Y, Obinata D, Yamaguchi K, Kaneko T, Kakutani S, Tokunaga M, Uemura Y, Sato Y, Enomoto Y, Nishimatsu H, Fujimura T, Fukuhara H, Takahashi S, Kume H. Kawai T, et al. Among authors: tokunaga m. J Immunother Cancer. 2022 Feb;10(2):e003965. doi: 10.1136/jitc-2021-003965. J Immunother Cancer. 2022. PMID: 35210308 Free PMC article.
Prognostic significance of the albumin-to-globulin ratio for advanced urothelial carcinoma treated with pembrolizumab: a multicenter retrospective study.
Taguchi S, Kawai T, Nakagawa T, Nakamura Y, Kamei J, Obinata D, Yamaguchi K, Kaneko T, Kakutani S, Tokunaga M, Uemura Y, Sato Y, Fujimura T, Fukuhara H, Enomoto Y, Nishimatsu H, Takahashi S, Kume H. Taguchi S, et al. Among authors: tokunaga m. Sci Rep. 2021 Aug 2;11(1):15623. doi: 10.1038/s41598-021-95061-z. Sci Rep. 2021. PMID: 34341416 Free PMC article.
Improved survival in real-world patients with advanced urothelial carcinoma: A multicenter propensity score-matched cohort study comparing a period before the introduction of pembrolizumab (2003-2011) and a more recent period (2016-2020).
Taguchi S, Kawai T, Nakagawa T, Miyakawa J, Kishitani K, Sugimoto K, Nakamura Y, Kamei J, Obinata D, Yamaguchi K, Kaneko T, Yoshida K, Yamamoto S, Kakutani S, Kanazawa K, Sugihara Y, Tokunaga M, Matsumoto A, Uemura Y, Akiyama Y, Yamada Y, Sato Y, Yamada D, Enomoto Y, Nishimatsu H, Ishikawa A, Tanaka Y, Nagase Y, Fujimura T, Fukuhara H, Takahashi S, Kume H. Taguchi S, et al. Among authors: tokunaga m. Int J Urol. 2022 Dec;29(12):1462-1469. doi: 10.1111/iju.15014. Epub 2022 Aug 22. Int J Urol. 2022. PMID: 35996761 Free PMC article.
Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab.
Taguchi S, Kawai T, Buti S, Bersanelli M, Uemura Y, Kishitani K, Miyakawa J, Sugimoto K, Nakamura Y, Niimi F, Kaneko T, Kamei J, Obinata D, Yamaguchi K, Kakutani S, Kanazawa K, Sugihara Y, Tokunaga M, Akiyama Y, Yamada Y, Sato Y, Yamada D, Enomoto Y, Nishimatsu H, Fujimura T, Fukuhara H, Nakagawa T, Takahashi S, Kume H. Taguchi S, et al. Among authors: tokunaga m. Immunotherapy. 2023 Aug;15(11):827-837. doi: 10.2217/imt-2023-0028. Epub 2023 May 16. Immunotherapy. 2023. PMID: 37191002
Efficacy of Combined Encorafenib and Binimetinib Treatment for Erdheim-Chester Disease Harboring Concurrent BRAFV600E and KRASG12R Mutations: A Case Report.
Hibino Y, Sakai R, Takahashi H, Takeda T, Hirose N, Tokunaga M, Washimi K, Yokose T, Kasajima R, Hiroshima Y, Miyagi Y, Nakajima H. Hibino Y, et al. Among authors: tokunaga m. Cancer Rep (Hoboken). 2024 Dec;7(12):e70093. doi: 10.1002/cnr2.70093. Cancer Rep (Hoboken). 2024. PMID: 39724464 Free PMC article.
Prognostic significance and therapeutic potential of guanosine triphosphate cyclohydrolase 1 in esophageal squamous cell carcinoma: clinical implications of ferroptosis and lipid peroxidation regulation.
Sakano M, Tomita Y, Kanazawa T, Ishibashi S, Ikeda M, Oshita H, Hananoi Y, Kato Y, Yamamoto K, Furukawa A, Kinoshita M, Haruki S, Tokunaga M, Kinugasa Y, Kurata M, Kitagawa M, Ohashi K, Yamamoto K. Sakano M, et al. Among authors: tokunaga m. Front Oncol. 2024 Dec 11;14:1459940. doi: 10.3389/fonc.2024.1459940. eCollection 2024. Front Oncol. 2024. PMID: 39723384 Free PMC article.
1,082 results